Work

Supplementary Figure S9 from Adaptive Regulation of dNTP Homeostasis Confers Osimertinib Resistance in EGFR-Mutant Non–Small Cell Lung Carcinoma

Year: 2026

Type: supplementary-materials

Abstract: Osimertinib decreases Chk1 mRNA levels, increases Chk2 mRNA levels, and increases Chk2 phosphorylation transiently

DOI: 10.1158/0008-5472.32873063

Authors: Qian Xie, Yingying Wang, Anthony Fernandez, Yi Lei, Yuanhang Gong, Jessica D. Hess, Lin Yang, Di Xin, Terence M. Williams, Li Zheng, Binghui Shen, Min Li

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7167017576

Cites:

Cited by:

Related to: